Home LiteratureArticle Details
PMID: 8437240 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

Journal of virology ·Vol. 67 ·No. 3 ·1993-03-00 ·Pages 1707-11

Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL

Abstract

To assess the possible role of cytotoxic T lymphocytes (CTLs) in containing the spread of human immunodeficiency virus in acutely infected individuals, the temporal evolution of the virus-specific CD8+ lymphocyte response was defined in simian immunodeficiency virus of macaques (SIVmac)-infected rhesus monkeys. A brief period of SIVmac plasma antigenemia was seen 9 to 16 days following intravenous infection with SIVmac, ending as the absolute number of CD8+ peripheral blood lymphocytes (PBLs) increased. In a prospective assessment of the ability of CD8+ lymphocytes of these monkeys to suppress SIVmac replication in autologous PBLs, inhibitory activity was detected as early as 4 days, with a more pronounced effect 12 to 16 days following infection. SIVmac Gag- and Nef-specific CD8+ effector cell activities were demonstrable in PBLs of animals by 2 weeks following virus inoculation. In fact, SIVmac-specific CTL precursors were documented in the PBLs of rhesus monkeys 4 to 6 days after SIVmac infection. These studies indicate that AIDS virus-specific CD8+ CTLs are present in PBLs within days of infection and may play an important role in containing the early spread of virus.

MeSH Terms
Acute Disease Animals CD8 Antigens/immunology Gene Products, gag/immunology Immunity, Cellular Immunity, Innate/immunology Macaca mulatta/immunology Simian Acquired Immunodeficiency Syndrome/immunology Simian Immunodeficiency Virus/immunology,pathogenicity T-Lymphocytes, Cytotoxic/immunology Time Factors Virulence
Chemicals
CD8 Antigens Gene Products, gag
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yasutomi Y
Harvard Medical School, New England Regional Primate Research Center, Southborough, Massachusetts 01772-9102.
Reimann K A
Lord C I
Miller M D
Letvin N L
References (30)
30 references, click to expand
  1. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals.
    Science. 1988 Apr 1;240(4848):64-6 PMID: 2451288
  2. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys.
    J Immunol. 1991 Jul 1;147(1):320-9 PMID: 1711081
  3. Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.
    J Exp Med. 1981 Aug 1;154(2):225-34 PMID: 6267157
  4. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
    N Engl J Med. 1982 Jul 1;307(1):7-13 PMID: 6281647
  5. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III.
    Science. 1985 Oct 4;230(4721):71-3 PMID: 2412295
  6. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool.
    Blood. 1985 Oct;66(4):961-6 PMID: 3876127
  7. In vitro growth characteristics of simian T-lymphotropic virus type III.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7053-7 PMID: 2996002
  8. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.
    J Clin Invest. 1986 Mar;77(3):977-84 PMID: 3081579
  9. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
    Nature. 1986 May 15-21;321(6067):239-43 PMID: 3086743
  10. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.
    Immunology. 1986 Jul;58(3):417-20 PMID: 2426185
  11. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.
    J Clin Invest. 1986 Sep;78(3):666-73 PMID: 3489008
  12. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.
    Science. 1986 Dec 19;234(4783):1563-6 PMID: 2431484
  13. Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Apposition of degenerative Langerhans cells and cytotoxic lymphocytes during the development of acquired immunodeficiency syndrome.
    Am J Pathol. 1987 Feb;126(2):199-207 PMID: 3030113
  14. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.
    Nature. 1987 Jul 2-8;328(6125):77-9 PMID: 2955227
  15. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  16. AIDS virus-specific cytotoxic T lymphocytes in lung disorders.
    Nature. 1987 Jul 23-29;328(6128):348-51 PMID: 3496542
  17. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses.
    Nature. 1987 Aug 6-12;328(6130):543-7 PMID: 3649576
  18. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Immunology. 1987 Sep;62(1):139-44 PMID: 2820868
  19. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes.
    J Immunol. 1988 Apr 1;140(7):2237-42 PMID: 2965185
  20. Development and testing of AIDS vaccines.
    Science. 1988 Jul 22;241(4864):426-32 PMID: 3293212
  21. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
    Nature. 1988 Dec 1;336(6198):484-7 PMID: 2461519
  22. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
    J Exp Med. 1989 Apr 1;169(4):1421-34 PMID: 2784486
  23. An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules.
    Eur J Immunol. 1989 Dec;19(12):2383-6 PMID: 2481593
  24. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.
    J Immunol. 1990 Jan 1;144(1):122-8 PMID: 2153161
  25. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.
    J Virol. 1990 Feb;64(2):656-63 PMID: 2296079
  26. Studies of cloned simian immunodeficiency virus-specific T lymphocytes. gag-specific cytotoxic T lymphocytes exhibit a restricted epitope specificity.
    J Immunol. 1990 May 1;144(9):3385-91 PMID: 1691757
  27. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.
    J Immunol. 1990 Jul 1;145(1):127-35 PMID: 1694201
  28. Animal models for AIDS.
    Immunol Today. 1990 Sep;11(9):322-6 PMID: 2206278
  29. Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis.
    J Immunol. 1990 Dec 1;145(11):3740-6 PMID: 2147200
  30. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.
    Nature. 1978 May 18;273(5659):238-9 PMID: 306072
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-03-00
Pages
1707-11
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237548
Subset
IM
Grants
NIAID NIH HHS · AI20729 · United States
NIAID NIH HHS · AI26507 · United States
NCI NIH HHS · CA50139 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]